Estabrook Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Estabrook Capital Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.8K	Buy	2,855 +63	+2%	+$906	0.01%	211
2026 Q1	$40.1K	Buy	2,792 +62	+2%	+$921	0.01%	205
2025 Q4	$41.1K	Buy	2,730 +58	+2%	+$871	0.01%	197
2025 Q3	$38.5K	Buy	2,672 +90	+3%	+$1.28K	0.01%	200
2025 Q2	$36.8K	Buy	2,582 +91	+4%	+$1.3K	0.01%	199
2025 Q1	$37.1K	Buy	2,491 +83	+3%	+$1.3K	0.01%	197
2024 Q4	$34.7K	Buy	+2,408	New	+$37.3K	0.01%	208

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Estabrook Capital Management's BMEZ Position: Q2 2026 in Review

Estabrook Capital Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 2.3% in Q2 2026, buying an estimated $906 and bringing the position to 2,855 shares worth $43.8K. The position accounts for 0.01% of the portfolio, ranked #211.

Estabrook Capital Management first reported a position in BMEZ in Q4 2024 and has held it in 7 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Estabrook Capital Management held 2,855 shares of BlackRock Health Sciences Trust II worth $43.8K as of Q2 2026.
Estabrook Capital Management bought 63 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $906.
BlackRock Health Sciences Trust II made up 0.01% of Estabrook Capital Management's portfolio in Q2 2026, its #211 holding.
Estabrook Capital Management first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and has held it in 7 quarters since.
89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Estabrook Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.